The shares remain up 3% to $115.55 in morning trading.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Abivax jumps 15% to $129.11 after report of exclusivity with AstraZeneca
- AstraZeneca granted exclusive period by Abivax for buyout, La Lettre reports
- Abivax management to meet with Citizens
- Buy Rating Underpinned by Obefazimod’s Differentiated IBD Profile, Oral Convenience, and Upcoming ABTECT & ENHANCE-CD Data Catalysts
- Qualcomm, Booking Holdings upgraded: Wall Street’s top analyst calls